Inhibition of tumor growth in vivo by hyaluronan oligomers

International Journal of Cancer

Volumn 77, Issue 3, 1998, Pages 396-401

  Zeng, Chunxun ^a   Toole, Bryan P ^b   Kinney, Shawn D ^c   Kuo, Jing Wen ^c   Stamenkovic, Ivan ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c Anika Therapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID DERIVATIVE;

ANIMAL CELL; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; DRUG EFFECT; MELANOMA; METASTASIS INHIBITION; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; STROMA;

ANIMALS; ANTIGENS, CD44; CELL DIVISION; FLOW CYTOMETRY; HYALURONIC ACID; LYMPHOMA; MELANOMA, EXPERIMENTAL; MICE; OLIGOSACCHARIDES; RECOMBINANT PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0031807394     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980729)77:3<396::AID-IJC15>3.0.CO;2-6     Document Type: Article

References (41)

1. ARCH, R., WIRTH, K., HOFMANN, M., PONTA, H., MATZKU, S., HERRLICH, P. and ZÖLLER, M., Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science, 257, 682-685 (1992).
2. ARUFFO, A., STAMENKOVIC, I., MELNICK, M., UNDERHILL, C. and SEED, B., CD44 is the principal cell surface receptor for hyaluronate. Cell, 61, 1303-1313 (1990).
3. BARTOLAZZI, A., NOCKS, A., ARUFFO, A., SPRING, F. and STAMENKOVIC, I., Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan. J. Cell Biol., 132, 1199-1208 (1996).
4. BARTOLAZZI, A., PEACH, R., ARUFFO, A. and STAMENKOVIC, I., Interaction between CD44 and hyaluronate is directly implicated in regulation of tumor development. J. exp. Med., 180, 53-66 (1994).
5. BENNETT, K., JACKSON, D., SIMON, J., TANCZOS, E., PEACH, R., MODRELL, B., STAMENKOVIC, I., PLOWMAN, G. and ARUFFO, A., CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor. J. Cell Biol., 128, 687-698 (1995).
6. BOURGUIGNON, L., LOKESHWAR, V., CHEN, X. and KERRICK, W., Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (gp85/CD44)-cytoskeleton interaction. J. Immunol., 151, 6634-6644 (1993).
7. CULTY, M., SHIZARI, M., THOMPSON, E. and UNDERHILL, C., Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: correlation with invasive potential. J. cell. Physiol., 160, 275-286 (1994).
8. ENTWISTLE, J., HALL, C. and TURLEY, E., HA receptors: regulators of signalling to the cytoskeleton. J. cell. Biochem., 61, 569-577 (1996).
9. FREEMAN, A., SOKOLOVSKY, M. and GOLDSTEIN, L., Biochim. biophys. Acta, 571, 127-136 (1979).
10. GALLUZO, E., ALBI, N., FIORUCCI, S., MERIGOLA, C., RUGGERI, L., TOSTI, A., GROSSI, C. and VELARDI, A., Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells. Europ. J. Immunol., 25, 2932-2939 (1995).
11. GOLDBERG, R., SEIDMAN, J., CHI-ROSSO, G. and TOOLE, B., Endogenous hyaluronate-cell surface interactions in 3T3 and simian virus-transformed 3T3 cells. J. biol. Chem., 259, 9440-9446 (1984).
12. GREEN, S., TARONE, G. and UNDERHILL, C., Aggregation of macrophages and fibroblasts is inhibited by a monoclonal antibody to the hyaluronate receptor. Exp. Cell Res., 178, 224-232 (1988).
13. GÜNTHERT, U., HOFMANN, M., RUDY, W., REBER, S., ZÖLLER, M., HAUSSMANN, I., MATZKU, S., PONTA, H. and HERRLICH, P., A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell, 65, 13-24 (1991).
14. HALL, C., WANG, C., LANGE, L. and TURLEY, E., Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activity. J. Cell Biol., 126, 575-588 (1994).
15. HALL, C., YANG, B., YANG, X., ZHANG, S., TURLEY, M., SAMUEL, S., LANGE, L., WANG, C., CURPEN, G., SAVANI, R., GREENBERG, A. and TURLEY, E., Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation. Cell, 82, 19-28 (1995).
16. HELDIN, P. and PERTOFT, H., Synthesis and assembly of the hyaluronan containing coats around normal human mesothelial cells. Exp. Cell Res., 208, 422-429 (1993).
17. KAYA, G., RODRIGUEZ, I., JORCANO, J.L., VASSALLI, P. and STAMENKOVIC, I., Selective suppression of CD44 in keratinocytes of mice gearing an antiscnse CD44 transgene driven by a tissue-specific promoter disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation. Genes Develop., 11, 996-1007 (1997).
18. KNUDSON, C., Hyaluronan receptor-directed assembly of chondrocyte pericellulur matrix. J. Cell Biol., 120, 825-834 (1993).
19. KNUDSON, W., DISWAS, D., LI, X., NEMEC, R. and TOOLE, B., The role and regulation of tumour-associated hyaluronan. Ciba Found. Symp., 143, 150-169 (1989).
20. KNUDSON, C. and KNUDSON, W., Hyaluronan-binding proteins in development, tissue homeustasis, and disease. FASEB J., 7, 1233-1247 (1993).
21. LESLEY, J. and HYMAN, R., CD44 can be activated to function as a hyaluronic acid receptor in normal murine T cells. Europ. J. Immunol., 22, 2719-2723 (1992).
22. LESLEY, J., HYMAN, R. and KINCADE, P., CD44 and its interaction with ECM. Adv. Immunol., 54, 271-335 (1993).
23. NAUJOKAS, M.F., MORIN, M., ANDERSON, M.S., PETERSON, M. and MILLER, J., The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44. Cell, 74, 257-268 (1993).
24. NEMEC, R., TOOLE, B. and KNUDSON, W., The cell surface hyaluronate binding sites of invasive human bladder carcinoma cells. Bioch. biophys. Res. Comm., 149, 249-257 (1987).
25. NOBLE, P., LAKE, F., HENSON, P. and RICHES, D., Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-α-dependent mechanism in murine macrophages. J. clin. Invest., 91, 2368-2377 (1993).
26. PAVASANT, P., SHIZARI, T. and UNDERHILL, C., Distribution of hyaluronan in the epiphysial growth plate: turnover by CD44-expressing osteoprogenitor cells. J. Cell Sci., 107, 2669-2677 (1994).
27. PILARSKI, L., MASELLIS-SMITH, A., BELCH, A., YANG, B., SAVANI, R. and TURLEY, E., RHAMM, a receptor for hyaluronan-mediated mutility, on normal human lymphocytes. thymocytes and malignant B cells: a mediator of malignancy? Leukemia Lymphoma, 14, 363-374 (1994).
28. SALMI, M., GRON-VIRTA, K., SOINTU, P., GRENMAN, R., KALIMO, H. and JALKANEN, S., Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin. J. Cell Biol., 122, 431-442 (1993).
29. SHERMAN, L., SLEEMAN, J., HERRLICH, P. and POSTA, H., Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression. Curr. Opinion Cell Biol., 6, 726-733 (1994).
30. SLEEMAN, J., ARMING, S., MOLL, J., HEKELE, A., RUDY, W., SHERMAN, L., KREIL, G., PONTA, H. and HERRLICH, P., Hyaluronate-independent metastatic behavior of CD44 variant-expressing pancreatic carcinoma cells. Cancer Res., 56, 3134-3141 (1996).
31. SY, M., Guo, Y. and STAMENKOVIC, I., Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein. J. exp. Med., 176, 623-627 (1992).
32. TAHER, E., TAHER, I., SMIT, L., GRIFFIOEN, A., SCHILDER-TOL, E., BORST, J. and PALS, S., Signaling through CD44 is mediated by tyrosine kinases. Association with p56lck in T lymphocytes. J. biol. Chem., 271, 2863-2867 (1996).
33. THOMAS, L., BYERS, H., VINK, J. and STAMENKOVIC, I., CD44 regulates tumor cell migration on hyaluronate-coated substrate. J. Cell Biol., 118, 971-977 (1992).
34. TOOLE, B., Glycosaminoglycans in morphogenesis. In: E. Hay (ed.), Cell biology of extracellular matrix, pp. 259-294, Plenum. New York (1981).
35. TURLEY, E., AUSTEN, L., MOORE, D. and HOARE, K., Ras-tiansformed cells express both CD44 and RHAMM hyaluronan receptors: only RHAMM is essential for hyaluronan-promoted locomotion. Exp. Cell Res., 207, 277-282 (1993).
36. UNDERHILL, C., Hyaluronan is inversely correlated with the expression of CD44 in the dermal condensation of the embryonic hair follicle. J. invest. Dermatol., 101, 820-826 (1993).
37. UNDERHILL, C., NOUYEN, H., SHIZARI, M. and CULTY, M., CD44 positive macrophages take up hyaluronan during lung development. Develop. Biol., 155, 324-336 (1993).
38. WEST, D. and KUMAR, S., The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. Exp. Cell Res., 183, 179-196 (1989).
39. Yu, Q. and TOOLE, B.P., Biotinylated hyaluronan as a probe for detection of binding proteins in cells and tissue. Biotechniques, 19, 122-129 (1995).
40. Yu, Q., TOOLE, B.P. and STAMENKOVIC, I., Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function. J. exp. Med., 186, 1985-1996 (1997).
41. ZAHALKA, M., OKON, E., GOSSLAR, U., HOLZMANN, B. and NAOR, D., Lymph node (but not spleen) invasion by murine lymphoma is both CD44- and hyaluronate-dependent. J. Immunol., 154, 5345-5355 (1995).